SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The Gambler who wrote (1099)2/6/1998 5:57:00 PM
From: Harry Ehrlich  Read Replies (1) of 2173
 
Gambler, my feeling is that you are correct. I think that AMLN is a good investment. D Right mentioned in an earlier post that several test subjects were continuing with the product, even though the test was over. I suspect that they felt better and possibly enjoyed some weight loss. That post confirmed to me that this was a good speculative play.

I also agree that there is not much downside. I am a position trader, holding stocks for several hours to several months. I bought in at 4 15/16 after that large reversal day. I tried to get in at 4 3/4 but was not fast enough that night. I got in the next morning at 4 15/16. But I bailed at 5 1/8, when I saw the price dropping the other day. Sometimes those reversal days have good follow through and sometimes they don't. I suspect the market wants to re-test that recent low. If that happens, I plan on jumping back in, as drops below 5 will present excellent buying opportunities.

The other possibility is that J&J will buy Amylin.

Good luck,
Harry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext